Novugen

Novugen is a pharmaceutical company focused on developing and manufacturing high-quality, affordable medicines to help improve access to treatment worldwide. With more than 30 years of global experience, the company aims to maintain a consistent quality standard that meets stringent regulatory requirements. Its research and development teams work on complex and niche pharmaceutical products, including oncology medicines, with a focus on addressing patients’ needs.

Novugen operates pharmaceutical and oncology manufacturing facilities in Malaysia, alongside a general pharmaceutical manufacturing facility in Uzbekistan, and works with Oncogen Pharma’s oncology facility in Pakistan. The company’s facilities hold approvals or accreditations from regulatory bodies including the USFDA, Malaysia’s NPRA, PIC/S, UAE MoHAP and Pakistan’s DRAP, as applicable to each site. Its product portfolio includes general medicines and oncology products, with launches and approvals reported in several markets, including the United States.

Novugen also offers partnership opportunities through in-licensing, out-licensing, technology transfer, contract development, contract manufacturing and co-development. Through research, manufacturing and strategic collaboration, it seeks to expand access to quality medicines across global markets.